Skip to Main content Skip to Navigation
Journal articles

Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?

Abstract : The influence of hyperhomocysteinemia (HHCy) on cardiovascular disease (CVD) remains unclear. HHCy is associated with inflammation and atherosclerosis, and it is an independent risk factor for CVD, stroke and myocardial infarction. However, homocysteine (HCy)-lowering therapy does not affect the inflammatory state of CVD patients, and it has little influence on cardiovascular risk. The HCy degradation product hydrogen sulfide (H2S) is a cardioprotector. Previous research proposed a positive role of H2S in the cardiovascular system, and we discuss some recent data suggesting that HHCy worsens CVD by increasing the production of H2S, which decreases the expression of adenosine A2A receptors on the surface of immune and cardiovascular cells to cause inflammation and ischemia, respectively.
Document type :
Journal articles
Complete list of metadata

https://hal.inrae.fr/hal-03329173
Contributor : Nelly Lucas <>
Submitted on : Monday, August 30, 2021 - 4:45:46 PM
Last modification on : Monday, September 6, 2021 - 10:28:49 AM

File

paganelli_ijms-21.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Franck Paganelli, Giovanna Mottola, Julien Fromonot, Marion Marlinge, Pierre Deharo, et al.. Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?. International Journal of Molecular Sciences, MDPI, 2021, 22 (4), pp.1690. ⟨10.3390/ijms22041690⟩. ⟨hal-03329173⟩

Share

Metrics

Record views

27

Files downloads

29